In a filing, Revolution Medicines Inc revealed its Chief Financial Officer Anders Jack unloaded Company’s shares for reported $0.4 million on May 03 ’24. In the deal valued at $40.03 per share,10,000 shares were sold. As a result of this transaction, Anders Jack now holds 101,959 shares worth roughly $3.98 million.
Then, GOLDSMITH MARK A sold 10,000 shares, generating $353,346 in total proceeds. Upon selling the shares at $35.33, the insider now owns 30,424 shares.
Before that, GOLDSMITH MARK A sold 7,500 shares. Revolution Medicines Inc shares valued at $266,122 were divested by the insider at a price of $35.48 per share. As a result of the transaction, GOLDSMITH MARK A now holds 452,879 shares, worth roughly $17.68 million.
Needham reiterated its Revolution Medicines Inc [RVMD] rating to a Buy in a research note published on April 12, 2024; the price target was $46. A number of analysts have revised their coverage, including Raymond James’s analysts, who increased its forecast for the stock in early April from “an Outperform” to “a Strong buy”. Piper Sandler began covering RVMD with “an Overweight” recommendation on March 11, 2024. BofA Securities revised its rating on January 05, 2024. It rated RVMD as “a Buy” which previously was an “a Neutral”.
Price Performance Review of RVMD
On Monday, Revolution Medicines Inc [NASDAQ:RVMD] saw its stock fall -2.86% to $39.05. Over the last five days, the stock has gained 5.23%. Revolution Medicines Inc shares have risen nearly 36.16% since the year began. Nevertheless, the stocks have risen 61.16% over the past one year. While a 52-week high of $40.21 was reached on 05/03/24, a 52-week low of $15.44 was recorded on 01/18/24. SMA at 50 days reached $33.38, while 200 days put it at $28.82. A total of 1.36 million shares were traded, compared to the trading of 1.22 million shares in the previous session.
Levels Of Support And Resistance For RVMD Stock
The 24-hour chart illustrates a support level at 38.28, which if violated will result in even more drops to 37.50. On the upside, there is a resistance level at 39.92. A further resistance level may holdings at 40.78. The Relative Strength Index (RSI) on the 14-day chart is 64.72, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 2.42, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 19.40%. Stochastics %K at 90.93% indicates the stock is a selling.
The most recent change occurred on January 04, 2024 when Wedbush began covering the stock and recommended ‘”an Outperform”‘ rating along with a $41 price target.
